{"id":"clm_663C199EF289","entity":"vertex-pharmaceuticals","predicate":"shares_outstanding","value":"253,718,831 shares","value_json":{"fp":"Q3","fy":2025,"accn":"0000875320-25-000232","form":"10-Q","filed":"2025-11-04","period":"Q3 FY2025","concept":"dei:EntityCommonStockSharesOutstanding"},"valid_from":"2025-10-31","valid_to":"2026-02-06","published":"2025-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Vertex Pharmaceuticals shares outstanding: 253,718,831 shares\", as of 2025-10-31 (until 2026-02-06). Claim clm_663C199EF289, https://asof.is/claim/clm_663C199EF289, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532025000232/0000875320-25-000232-index.htm.","url":"https://asof.is/claim/clm_663C199EF289","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B7B98F7F000A","supersedes":["clm_ABBFFDB9DFAC"],"first_seen_at":"2026-11-08T17:02:27.400953+00:00","updated_at":"2026-11-08T17:02:34.884621+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000232/0000875320-25-000232-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2025, filed 2025-11-04"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}